Chemomab Therapeutics (CMMB) Q1 2024 Earnings

May 9Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.72
-0.49
-0.25
-0.02

Details

Expected EPS
N/A
Actual EPS
-0.28
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Chemomab Therapeutics⁩ (⁦CMMB⁩) has reported earnings of ⁦-0.28⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts